
Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) has a promising role in the initial staging of prostate cancer, and is more effective than conventional imaging in characterizing intraprostatic tumors, pelvic nodal disease, and distant metastases. PSMA PET is also an effective tool for planning definitive therapy.
Like
Save
Share